Navigation Links
Erectile Dysfunction a Strong Harbinger of Heart Trouble
Date:5/19/2008

Studies found having ED increased risk in diabetic men

MONDAY, May 19 (HealthDay News) -- Findings from two studies of men with diabetes add to the evidence that erectile dysfunction can be a powerful early warning sign for serious heart disease.

A Hong Kong study of 2,306 men with diabetes but no signs of heart disease found that those with erectile dysfunction at the start were 58 percent more likely to have a heart attack or other major cardiac problem over the next four years than those with adequate sexual function.

And Italian physicians who followed 291 men who had diabetes and early coronary heart disease for four years reported similar numbers -- those with erectile dysfunction were twice as likely as men without the problem to have major adverse events, including strokes.

There's a physical connection between male sexual failure and heart disease, involving the effect of diabetes on the nervous system and the blood vessels, said Dr. E. Scott Monrad, a professor of clinical medicine at Albert Einstein College of Medicine in New York City.

"Neuropathy would interfere with the neurogenic responses feeding into proper erection," Monrad said. "And obstruction of blood flow into the arteries reduces the pressure needed to achieve erection."

It has been known that erectile dysfunction shares many risk factors with coronary heart disease, such as high blood pressure, smoking and diabetes, according to Dr. Robert A. Kloner, a professor of medicine at the University of Southern California, who wrote an accompanying editorial on the reports, which were expected to be published in the May 27 issue of the Journal of the American College of Cardiology.

"What is new here is that erectile dysfunction remained a significant risk factor for developing heart disease after controlling for other cardiovascular risk factors," Kloner said in a statement.

"These reports add two thin
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Cialis Eases Erectile Dysfunction After Spinal Cord Injury
2. Erectile Dysfunction: A Harbinger of Heart Trouble
3. Diabetic Men With Erectile Dysfunction Urged to Consult Their Doctors During November - American Diabetes Month
4. Warner Chilcott and NexMed Sign U.S. Collaboration for Topical Alprostadil Treatment for Erectile Dysfunction
5. Horphags Prelox(R) Provides Over-the-Counter Solution in Battle Against Erectile Dysfunction
6. FDA Approves Cialis(R) (tadalafil) for Once Daily Use for the Treatment of Erectile Dysfunction
7. The Penis Diet: A Healthy Solution for Men Challenged by Erectile Dysfunction
8. AUA 2008: Maxi-K gene transfer may prove to be safe and effective erectile dysfunction treatment
9. Vocal cord dysfunction may be caused by work
10. Eating AGE-Rich Foods Causes Dysfunction Linked to Heart Disease
11. Dysfunctional families and bad neighborhoods may worsen asthma in children and adolescents
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Erectile Dysfunction a Strong Harbinger of Heart Trouble
Erectile Dysfunction a Strong Harbinger of Heart Trouble
Other Medicine News:Health News:Baxter Reports Strong Third Quarter Sales and Earnings 2Health News:Baxter Reports Strong Third Quarter Sales and Earnings 3Health News:Baxter Reports Strong Third Quarter Sales and Earnings 4Health News:Baxter Reports Strong Third Quarter Sales and Earnings 5Health News:Baxter Reports Strong Third Quarter Sales and Earnings 6Health News:Baxter Reports Strong Third Quarter Sales and Earnings 7Health News:Baxter Reports Strong Third Quarter Sales and Earnings 8Health News:Baxter Reports Strong Third Quarter Sales and Earnings 9Health News:Baxter Reports Strong Third Quarter Sales and Earnings 10Health News:Baxter Reports Strong Third Quarter Sales and Earnings 11Health News:Baxter Reports Strong Third Quarter Sales and Earnings 12Health News:Baxter Reports Strong Third Quarter Sales and Earnings 13Health News:Baxter Reports Strong Third Quarter Sales and Earnings 14Health News:Baxter Reports Strong Third Quarter Sales and Earnings 15Health News:Baxter Reports Strong Third Quarter Sales and Earnings 16Health News:Baxter Reports Strong Third Quarter Sales and Earnings 17Health News:Baxter Reports Strong Third Quarter Sales and Earnings 18Health News:Baxter Reports Strong Third Quarter Sales and Earnings 19Health News:Baxter Reports Strong Third Quarter Sales and Earnings 20Health News:Baxter Reports Strong Third Quarter Sales and Earnings 21Health News:Baxter Reports Strong Third Quarter Sales and Earnings 22Health News:Baxter Reports Strong Third Quarter Sales and Earnings 23Health News:Baxter Reports Strong Third Quarter Sales and Earnings 24Health News:Baxter Reports Strong Third Quarter Sales and Earnings 25Health News:Baxter Reports Strong Third Quarter Sales and Earnings 26Health News:Baxter Reports Strong Third Quarter Sales and Earnings 27Health News:Baxter Reports Strong Third Quarter Sales and Earnings 28Health News:XTend Medical (XDMC) Adds New Bluetooth(R) Telemedicine Products From A&D Medical 2Health News:Holiday Gifts That Help Fight Alzheimer's Disease 2Health News:QLT announces Visudyne(R) sales for third quarter and provides Visudyne sales guidance for 2007 2Health News:QLT announces Visudyne(R) sales for third quarter and provides Visudyne sales guidance for 2007 3Health News:Practices in Health & Disability Insurance - The Lives & Wealth They Cost America 2
Breaking Medicine Technology:VidaySalud.com(TM) Reaches 1,000,000 Page Views In its First Six Months of Operation 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 3HealthSport, Inc. Closes Stock Purchase Agreement With SMI Manufacturing - Receives $2.5 Million 2HealthSport, Inc. Closes Stock Purchase Agreement With SMI Manufacturing - Receives $2.5 Million 3AMERIGROUP Corporation Names Two New Executives 58138 1AMERIGROUP Corporation Names Two New Executives 58138 2AMERIGROUP Corporation Names Two New Executives 58138 3Bubble Trouble Team Hits the Lab for Good Hygiene 58133 1Bubble Trouble Team Hits the Lab for Good Hygiene 58133 2Bubble Trouble Team Hits the Lab for Good Hygiene 58133 3Bubble Trouble Team Hits the Lab for Good Hygiene 58133 4Sinobiopharma Reports Highlights From Audited Financial Results for the Fiscal Year Ended May 31 2009 14227 1Sinobiopharma Reports Highlights From Audited Financial Results for the Fiscal Year Ended May 31 2009 14227 2Sinobiopharma Reports Highlights From Audited Financial Results for the Fiscal Year Ended May 31 2009 14227 3
Other Medicine Technology:New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly,Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer,Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by,Paclitaxel 2New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly,Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer,Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by,Paclitaxel 3New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly,Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer,Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by,Paclitaxel 4New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly,Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer,Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by,Paclitaxel 5Data Demonstrated Metastatic Melanoma Response to Investigational,Immunotherapy Ipilimumab 2Data Demonstrated Metastatic Melanoma Response to Investigational,Immunotherapy Ipilimumab 3Data Demonstrated Metastatic Melanoma Response to Investigational,Immunotherapy Ipilimumab 4Data Demonstrated Metastatic Melanoma Response to Investigational,Immunotherapy Ipilimumab 5Data Demonstrated Metastatic Melanoma Response to Investigational,Immunotherapy Ipilimumab 6Data Demonstrated Metastatic Melanoma Response to Investigational,Immunotherapy Ipilimumab 7